UCB

Allee de la Recherche 60
Brussels
1070
Belgium

+32 2 559 99 99

Activities

Related Content

Therapeutics: dapirolizumab for systemic lupus erythematosus

UCB Pharma chooses South Korean CDMO for the third time

Increasing competition in the psoriasis market

MRC forges two new deals with industry to speed drug discovery

UCB receives EMA approval for pre-filled pen using Bespak Technology

Heptares joins consortium applying cryo-electron microscopy to structure-based drug discovery

Latest EU drug approvals span range of health issues

UCB and Baylor College of Medicine enter neurodegeneration alliance

Leukaemia – inotuzumab ozogamicin

Lannett to acquire Kremers Urban Pharmaceuticals for US$1.23bn

Jobs and People

Steve Turley joins UCB as Managing Director for UK and Ireland

UCB scientists embark on 300-mile cycling challenge

CEO of UCB joins Ministerial Industry Strategy Group (MISG)

Aesica makes European appointments

Similar Companies